Patents by Inventor Gary L. Kieft

Gary L. Kieft has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Truncated soluble tumor necrosis factor type-I and type-II receptors
    Patent number: 6989147
    Abstract: Disclosed are novel proteins, referred to as tumor necrosis factor binding proteins, that modulate the activity of tumor necrosis factor. Also disclosed are processes for obtaining the tumor necrosis binding proteins by recombinant genetic engineering techniques.
    Type: Grant
    Filed: June 15, 2001
    Date of Patent: January 24, 2006
    Assignee: Amgen Inc.
    Inventors: Eric F. Fisher, Carl K. Edwards, III, Gary L. Kieft
  • Truncated soluble tumor necrosis factor type-I and type-II receptors
    Publication number: 20030054439
    Abstract: Disclosed are novel proteins, referred to as tumor necrosis factor binding proteins, that modulate the activity of tumor necrosis factor. Also disclosed are processes for obtaining the tumor necrosis binding proteins by recombinant genetic engineering techniques.
    Type: Application
    Filed: June 15, 2001
    Publication date: March 20, 2003
    Applicant: Amgen Inc.
    Inventors: Eric F. Fisher, Carl K. Edwards, Gary L. Kieft